Inicio › Cáncer de seno › Arkansas
Ensayos clínicos de Cáncer de seno en Arkansas
17 estudios sobre Cáncer de seno buscan participantes en Arkansas.
Ciudades en Arkansas
- Little Rock8 estudios
- Springdale5 estudios
- Hot Springs4 estudios
- Fort Smith4 estudios
- Jonesboro3 estudios
Texto oficial del estudio (inglés)
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
- CARTI Cancer Center, Little Rock
ReclutandoFase 3
Edades de 18 a 100 · Todos los sexos · Actualizado el 2 oct 2026 · NCT05827081Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Mercy Hospital Fort Smith, Fort Smith
- CARTI Cancer Center, Little Rock
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 40 a 75 · Todos los sexos · Actualizado el 2 oct 2026 · NCT05334069A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
- Research Site, Springdale
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT06103864Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
- Clinical Trial Site, Hot Springs
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 23 sept 2026 · NCT07085767A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
- Genesis Cancer and Blood Institute, Hot Springs
- Highlands Oncology Group, Springdale
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT07174336ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
- Highlands Oncology Group, Springdale
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 17 sept 2026 · NCT07173751A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
- Highlands Oncology Group, PA, Springdale
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 15 sept 2026 · NCT06492616A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With Early-stage and Advanced HR+ Breast Cancer
- Genesis Cancer and Blood Institute, Hot Springs
ReclutandoFase 1
Edades de 18 a 55 · Mujeres · Actualizado el 9 sept 2026 · NCT07310420Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
- Mercy Hospital Fort Smith, Fort Smith
- NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro, Jonesboro
- Baptist Health Medical Center - Little Rock, Little Rock
- y 2 más
ReclutandoFase 3
Edades de 18 a 60 · Mujeres · Actualizado el 2 sept 2026 · NCT05879926Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
- University of Arkansas for Medical Sciences, Little Rock
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 17 ago 2026 · NCT06500481A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
- Local Institution - 0303, Hot Springs
ReclutandoFase 2/3
Edades de 18 en adelante · Todos los sexos · Actualizado el 10 ago 2026 · NCT06926868E-Mindfulness Approaches for Living After Breast Cancer
- Mercy Hospital Fort Smith, Fort Smith
- NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro, Jonesboro
- University of Arkansas for Medical Sciences, Little Rock
ReclutandoFase 3
Edades de 18 a 50 · Todos los sexos · Actualizado el 4 ago 2026 · NCT06748222De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
- University of Arkansas for Medical Sciences, Little Rock
ReclutandoFase 3
Edades de 50 a 70 · Todos los sexos · Actualizado el 23 abr 2026 · NCT04852887Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
- Mercy Hospital Fort Smith, Fort Smith
- NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro, Jonesboro
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 17 mar 2026 · NCT06418204Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients
- Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock
ReclutandoFase 2
Edades de 18 en adelante · Mujeres · Actualizado el 5 mar 2026 · NCT01530373SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Little Rock
ReclutandoEstudio observacional
Todas las edades · Todos los sexos · Actualizado el 28 oct 2025 · NCT03452774BostonGene and Exigent Genomic INsight Study
- Highlands Oncology Group, Rogers
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 17 feb 2025 · NCT06272864De ClinicalTrials.gov, datos obtenidos el 5 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.